This inventor holds 22 USPTO granted patents and 9 published patent applications, plus 4 CIPO patents and 6 EPO patents, primarily in Polymer Science. Top assignees: University of Illinois, Massachusetts Institute of Technology, The Brigham and Women's Hospital, Inc.. Active years: 2014-2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Urbana, IL (US) (2018)
- Chicago, IL (US) (2019)
- Champaign, IL (US) (2014 - 2022)
Company Filing History:
19 out of 2,432 
3 out of 8,594 
3 out of 1,429 
Years Active: 2014-2022
Areas of Expertise:
Title: **Jianjun Cheng: Innovator in Patent Development and Cancer Research**
Introduction
Jianjun Cheng is a prominent inventor based in Champaign, IL, recognized for his groundbreaking contributions to the fields of chemistry and biomedical engineering. With a total of 22 patents to his name, his innovations focus on enhancing the effectiveness of various substances, particularly in the realm of cancer treatment and detergent applications.
Latest Patents
Cheng's recent patents demonstrate his focus on developing advanced solutions. One notable patent is for "Tetraacetyldiamine and triacetyldiamine derivatives useful as bleach activators." This invention relates to bleach activator compositions, featuring tetraacetyldiamine and triacetyldiamine derivatives. These compounds serve as effective bleach activators, showcasing their potential application in detergents or biocides.
Another significant patent involves "Trigger-activatable sugar conjugates for cancer-selective labeling and targeting." This innovation introduces compounds designed for the selective labeling of cell-surface sugars in cancer cells. Activated by triggers specific to cancer cells, these compounds label the surface sugar with an azide chemical group, allowing for targeted drug delivery while minimizing toxicity. It illustrates Cheng’s dedication to enhancing cancer treatment methodologies.
Career Highlights
Cheng has made significant contributions within esteemed institutions, including the University of Illinois and the Massachusetts Institute of Technology (MIT). His time at these institutions has facilitated expansive research opportunities that culminated in numerous patents and innovative solutions directed towards chemical and biomedical applications.
Collaborations
Throughout his career, Cheng has collaborated with notable figures in his field, including Hanze Ying and Robert S. Langer. These partnerships have contributed significantly to the collective advancement of research, particularly in the realms of drug delivery systems and targeted cancer therapies.
Conclusion
Jianjun Cheng continues to be an influential figure in innovation, particularly in regard to cancer research and chemical applications. His extensive patent portfolio not only showcases his inventive spirit but also his commitment to enhancing both everyday consumer products and critical medical treatments. As he advances further in his career, the impact of his work will undoubtedly continue to resonate across various fields.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile